Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
> China Pharma Providers
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
China Pharma Providers
Type:
CMO-API
Title:
Heze Ruiying Pharmaceutical Group Co Ltd
Chinese
CSertification:
GMP
International
Certification:
n/a
Primary Location:
Other Cities
China
Contact Info:
Marketing Headquarters:
Room 1001, No.48, Lane 1030 YanAn Xi Road, Shanghai, China
Tel: +86 21 6210 9662
Fax: +86 21 6210 9095
Email: flj@rychem.com; php@rychem.com; wlc@rychem.com
Webpage:
www.ruiyingpharma.com
HQ
Contact Info:
66 Taishan Road, Heze, Shandong 274039, China
Tel: +86 530 585 0184
Fax: +86 530 585 6118
Email: chao@rychem.com
Additional
Contact Info:
n/a
Description:
The Heze Ruiying Pharmaceutical Group is a comprehensive manufacturer of APIs, fine chemicals and pharmaceutical intermediates. It has six manufacturing subsidiaries: Heze Ruiying Pharmaceutical Group Co Ltd, Heze Ruiyuan Chemical Co Ltd, Heze Ruichen Technology Development Co Ltd, Heze Ruichang Chemical Co Ltd, Caoxian Ruida Chemical Co Ltd and Jinyi Biopharmaceutical Co Ltd, and two other technology development companies. The group owns self-support import and export rights.
Total annual production throughputs are: semi-synthetic penicillin sterile bulk drugs (200mts), cephalosporin sterile bulk drugs (500mts), penicillin intermediates (300mts), cephalosporin intermediates (500mts), fluoro-series intermediates (500mts) and other fine chemicals (300mts).
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit